The above results suggested that both ajugol in RR and isoacteoside in RRP can modulate the contents of IL-1β, IFN-γ, IL-4, NO, and G-CSF in Aβ-exposed mouse BV2 microglial cells, thereby exerting anti-AD effects. Here, IL4 is linked to Alzheimer disease.